News | March 31, 2014

BioCardia Receives CE Mark for Morph AccessPro Steerable Introducer

March 31, 2014 — BioCardia Inc. announced it received CE mark for its Morph AccessPro steerable introducer, designed for easier navigation through the vasculature during delivery of biotherapeutics and medical devices.

The steerable thin-walled catheter shaft technology provides a flexible pathway for biologic delivery systems, balloon dilatation catheters, stents, guidewires and micro infusion systems. The unique introducer is designed to enhance physician control and reduce complications and catheter exchanges, minimizing procedure time and radiation exposure. It will be commercially available in the European Union in the coming months.

“Many times, the primary reason for failure of a particular procedure is the inability to gain access into the aortic branches with a guide catheter or guide sheath,” said Rodney S. Badger, M.D., chief of interventional cardiology and associate professor of medicine for the University of Utah. “This introducer is valuable today to improve access for aorto-ostial procedures, thereby enhancing safety and shortening procedure times. It also has future potential to enhance biotherapeutic interventions for diseases of the organs fed by these arteries, such as inflammatory bowel diseases, renal diseases and even diseases involving the pancreas.”

Current commercially available guide catheters have pre-formed distal curves shaped like a “hockey stick” or a “shepherd’s crook,” designed to maneuver within specific vascular anatomical configurations. If a patient’s anatomy is complicated and does not match the catheter shape, access can be time-consuming and difficult to achieve.

The Morph AccessPro enables a physician to customize the catheter shape to an individual patient’s anatomy, allowing access to the contra-lateral superficial femoral artery (SFA) all the way down to the trifurcation, the renal arteries and the mesenteric arteries.

The Morph AccessPro is currently being used commercially in 350 U.S. hospitals and has been used in thousands of cases to date.

For more information: www.biocardia.com

Related Content

TVA Medical Receives CE Mark for Next-Generation EverlinQ 4 EndoAVF System
News | Vascular Access | October 04, 2017
TVA Medical Inc. announced that its everlinQ 4 endoAVF System has received CE Mark in the European Union. The...
Merit Medical, FDA Class I recall, Prelude Short Sheath Introducer
News | Vascular Access | March 31, 2017
The U.S. Food and Drug Administration (FDA) announced it has initiated a Class I recall of the Merit Prelude Short...
Halo One Thin-Walled Guiding Sheath

The Halo One Thin-Walled Guiding Sheath.

News | Vascular Access | January 31, 2017
January 31, 2017 — Bard Peripheral Vascular Inc.
Technology | Vascular Access | January 10, 2017
January 10, 2017 — Teleflex Inc.
Teleflex, AVA 2016 Congress, Association for Vascular Access
News | Vascular Access | September 20, 2016
September 20, 2016 — Teleflex Inc.
Gore, DrySeal Flex Introducer Sheath, endovascular repair, EVAR
Technology | Vascular Access | August 30, 2016
W. L. Gore & Associates Inc. (Gore) announced the commercial availability of the Gore DrySeal Flex Introducer...
Access Scientific, PowerWand XL midline catheter
Technology | Vascular Access | August 10, 2016
August 10, 2016 — Access Scientific introduced the PowerWand XL, a companion to the PowerWand All-in-One, in July.
heart attack patients, rescue PCI, transradial and transfemoral approach, Perelman School of Medicine
News | Vascular Access | January 04, 2016
January 4, 2016 — In a comparison of bleeding complications and mortality between transradial and transfemoral...
Overlay Init